drugset / Trial / NCT04169269
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective of this study is to compare oral rivaroxaban with injectable enoxaparin in orthopaedic trauma patients to determine if orally administered rivaroxaban once daily carries greater compliance and overall satisfaction than enoxaparin self-administered by subcutaneous injection once daily.
Timeline
- Start
- 2020-01-13
- Primary completion
- 2020-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Comparator | Rivaroxaban | Other / unclassified | 10 mg | Oral |